CD8A and neoplasm: McGrail et al. divided TMB-high tumors into two groups, those in which the neoantigen levels correlated with the number of CD8 T cells in the tumor and those in which the number of CD8 T cells did not correlate, and analyzed the effect of treatment with ICIs [48].